Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial - Concepedia

Concepedia

Publication | Open Access

Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial

DOI Full Paper Access

19

Citations

32

References

2022

Year

Roberto De Icco, Gloria Vaghi, Marta Allena, Natascia Ghiotto, Elena Guaschino, Daniele Martinelli, Lara Ahmad, Michele Corrado, Federico Bighiani, Federica Tanganelli,

The Journal of Headache and Pain

References

	Year	Citations

Page 1